Date: 2026-05-28 00:15:59Image: UnknownViews: {Random Number} +
順藥(6535)今日僅國票發布績效評等報告,彙整評價為中立,順藥目標價為155元。今日僅家績效
預估 2026年度營收約1.77億元、發布EPS約-1.07元。為中為元
想知道更多股市相關資訊,立目oyi官网可點擊下方連結,券商券商從籌碼K線APP查詢哦!評等評等評價
https://www.cmoney.tw/r/2/d04n9s
Tags:
The text and image materials published on this site are adapted or organized for non-commercial purposes. Copyright belongs to the original authors. If there is infringement or illegality, please contact us for deletion. For reprinting, please keep the original address: http://www.echarpe-colimacon.com/html/770d2399206.html
oyi官网
Talk about your feelings and share your stories
【12:41 即時新聞】高力(8996)股價勁揚逾9%至1245元,受益AI液冷散熱題材+均線多頭與大戶持股偏多支撐
【即時新聞】健鼎(3044)首季EPS達5.61元創歷年新高4月營收年增29%
全市場高配息冠軍:年配息率前 10 大共同基金大盤點
【即時新聞】福懋今日召開重訊記者會,副總說明擬處分閒置土地事宜
05/26 主動式ETF共識|賣單湧現,資金轉搶封測與ABF載板
欧交易所App最新更新功能解析
【26Q1財報公告】大東電(1623) Q1 營收18.6234億元,創歷史新高,季增 5.2%、年成長 12.42%
規模最大的台股共同基金怎麼挑?安聯台灣科技、安聯台灣大壩與國泰小龍的關鍵對決
欧义交易所全新升级,引领数字货币交易新潮流
易欧交易所苹果,数字货币市场的新宠儿
Copyright 2005-2020 {Website URL} 【{Website Name}】 All Rights Reserved | 
Disclaimer: Some information and image materials are sourced from the Internet. If the content infringes or violates regulations, please contact us. We will process it within three working days. Internet bad information report email: {Contact Email}